Arnaub Chatterjee, Datavant president and GM of life sciences, says the company will streamline data linking and evidence generation across real-world and clinical trial data.

The funds will be used to increase the development of GAIA-based Alzheimer's Disease drugs and widen the pipeline of blockbuster drug candidates.

The company will use the funds to move into the female health space and increase screening and preventive care.

The news comes alongside the U.S. Department of Defense’s announcement of $200 million contracts awarded to xAI, Anthropic, Google and OpenAI for AI implementation.

The funds will be used to improve the company's flight cadence and expand its pharmaceutical lab capabilities.

Researchers from Asan Medical Center, one of South Korea's largest hospitals, have developed a generative AI model that can ...

NEW YORK - At HIMSS AI Forum on Friday, during the talk, "The future of people centered care: earning (or losing) trust by leveraging AI and synthetic research," Dr. Adrienne Boissy, chief medical ...

A new AI algorithm developed by researchers from the University of Western Australia has been found to better predict the ...

The Focalist system aims to combine handheld robotics with real-time imaging to enable clinicians to place needles more ...

The organizations will co-develop AI playbooks, tools, a new certification program and best practices for health AI.

Also, four tuberculosis screening AI solutions from Asia-Pacific are among those recommended by the World Health Organization ...

Flinders University has developed an online program that seeks to improve the way people with inflammatory bowel disease (IBD ...